January 23, 2015 10:49 AM
A 2.9 million dollar boost for applied metabolomics technology in Alberta
Yesterday was a pretty good day for research in Alberta.
Especially for applied research in metabolomics which received 2.9 million dollars in funding from a group of partners led by Western Economic Diversification. Genome Alberta has been nurturing metabolomics research for several years now and led this latest effort which brought together WD, Genome Canada, the University of Alberta, National Institute of Nanotechnology, Alberta Innovates Health Solutions, and Metabolomics Technologies Inc. (MTI).
The money will go towards assessment equipment which the Metabolomics Innovation Centre at the U of A will use to speed up the commercialization of new technologies.
The full media release is available on an earlier blog post
The announcement was made at the University of Alberta by Michelle Rempel, Minister of State for Western Economic Diversification. There were representatives from all of the funders on hand including Genome Alberta's CEO David Bailey (shown at the left).
Freelance broadcaster Don Hill was on hand to find out why so many organization were eager to get involved and he sent us this podcast
January 26, 2015 2:08 PM
Private sector engages The Metabolomics Innovation Centre
Michelle Rempel, the , Minister of State for Western Economic Diversification announced last week an investment of $2,983,800 towards state-of-the-art metabolomics assessment equipment to be housed at
the Metabolomics Innovation Centre at the University of Alberta. The equipment will help the TMIC expands commercial services to test, validate, and assemble prototype kits to cost-effectively create more accurate and less invasive medical tests.
Minister Rempel has a background in innovation and IP, and talked about success in commercializing academic research here
immediately after the announcement.
As a measure of the commercial demand to get metabolomics research out of the lab and into the marketplace, Cell MedX Corp announced today
that it will use The Metabolomics Innovation Centre to conduct metabolomics profiling of blood samples collected during the discovery phase of a pilot trial which CellMedX started on January 9.
Cell MedX Corp
. is an early development stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications.
January 20, 2015 2:23 PM
Centre of the metabolomic universe can be found at the University of Alberta
n - stuff out.
That's pretty much a basic fact of life for people and it holds true right on down to the basic cellular level.
If you start to compare what a healthy organism takes in, how it is broken down, and what comes out as waste you're getting close to the science of metabolomics. Figure out how the process differs in healthy organisms vs diseased organisms and you start to develop a diagnostic tool.
That's been the life's work of David Wishart who now heads up The Metabolomics Innovation Centre
at the University of Alberta. His work and the applied research taking place at the Centre have put Edmonton onto a world stage where metabolomics is the rising star playing a role in new therapies and treatments.
Journalist Don Hill talked with Dr. Wishart about metabolomics and TMIC and sent us this report.
(you might want to note the part about tricorders - Star Trek is getting closer! )
January 16, 2015 9:04 AM
A World First - Discovery of a Personalized Therapy for Cardiovascular Disease
Media Release, January 12, 2015. Researchers at the Montreal Heart Institute announced today results showing that patients with cardiovascular disease and the appropriate genetic background benefit greatly from the new medication dalcetrapib, with a reduction of 39% in combined clinical outcomes including heart attacks, strokes, unstable angina, coronary revascularizations and cardiovascular deaths. These patients also benefit from a reduction in the amount of atherosclerosis (thickened walls) in their vessels. The detailed results are published in the prestigious Journal Circulation Cardiovascular Genetics. This discovery may also pave the way for a new era in cardiovascular medicine, with personalized or precision drugs.
January 11, 2015 9:49 AM
Science Fair Season in Alberta 2015
If you follow #edchat, you might be familiar with #STEM, #pbl, #flipped, #NGSS, or #project but it is unlikely that you will ever see #lecture, #drillandreview, #traditionallearning, #presenter or #standanddeliver.
Have I completely lost you? Let me give some clarity to the sentence above. In social media such as Twitter, Google+ and Facebook words, phrases and acronyms preceded by the symbol # are a way of tagging the ideas. Social media hipsters didn’t describe the # symbol as the ‘pound sign’ or the ‘number sign’, they came up with the descriptor ‘hashtag’ to describe this usage. It became so widespread that the term hashtag was officially added to the Oxford English Dictionary
in June 2014.
December 27, 2014 6:36 PM
Genomics 2014: A year on our blogs - Genome Alberta
With 2014 coming to a close, I took a second look at our blog posts for the year and linked some of them in Prezi to illustrate the many science topics we explored. For me, the year began and ended with Gerry’s Gene Scene YouTube videos. In January, I shared my excitement over learning about the thousand dollar genome. At the end of the year I was participating in a blogging festival supported by Science Borealis
. In between those two, a number of other videos were posted, including interviews with student winners of the Genome Alberta science fair awards. Science fair season in Alberta began for us in February and culminated with the Canada-Wide Science Fair in Windsor, Ontario. We included a five part series, ‘the diary of a delegate’ on our blog.